Abstract
The application of fluorescent receptor ligands has become widespread, incited by two important reasons. “Seeing is believing”—it is possible to visualize in real time in live cells ligand–receptor interactions, and to locate the receptors with subcellular precision allowing one to follow, e.g., internalization of the ligand–receptor complex. The high sensitivity of photon detection permits observation of on the one hand receptor–ligand interactions on cells with low, native receptor abundance, and on the other of individual fluorophores unveiling the stochastic properties of single ligand–receptor complexes.
The major bottlenecks that impede extensive use of fluorescent ligands are due to possible dramatic changes of the pharmacological properties of a ligand upon chemical modification and fluorophore conjugation, aggravated by the observation that different fluorophores can provoke very dissimilar effects. This makes it virtually impossible to predict beforehand which labelling strategy to use to produce a fluorescent ligand with the desired qualities.
Here, we focus on the design, synthesis, and evaluation of a high-affinity fluorescent antagonist for the ionotropic serotonin type-3 receptor.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baindur N, Triggle DJ (1994) Concepts and progress in the development and utilization of receptor-specific fluorescent ligands. Med Res Rev 14:591–664
Baindur N, Triggle DJ (1994) Selective fluorescent ligands for pharmacological receptors. Drug Dev Res 33:373–398
Kuder K, Kiéc-Kononowicz K (2008) Fluorescent GPCR ligands as new tools in pharmacology. Curr Med Chem 15:2132–2143
McGrath JC, Arribas S, Daly CJ (1996) Fluorescent ligands for the study of receptors. Trends Pharmacol Sci 17:393–399
Middleton RJ, Kellam B (2005) Fluorophore-tagged GPCR ligands. Curr Opin Chem Biol 9:517–525
Colquhoun D (1998) Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 125:924–947
Vernekar SKV, Hallaq HY, Clarkson G, Thompson AJ, Silvreti L, Lummis SC, Lochner M (2010) Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives. J Med Chem 53:2324–2328
Lummis SC, Martin IL (1992) Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells. Mol Pharmacol 41:18–23
Boess FG, Lummis SC, Martin IL (1992) Molecular properties of 5-hydroxytryptamine3 receptor-type binding sites purified from NG108-15 cells. J Neurochem 59:1692–1701
Tairi AP, Hovius R, Pick H, Blasey H, Bernard A, Surprenant A, Lundstrom K, Vogel H (1998) Ligand binding to the serotonin 5-HT3 receptor studied with a novel fluorescent ligand. Biochemistry 37:15850–15864
Wohland T, Friedrich K, Hovius R, Vogel H (1999) Study of ligand-receptor interactions by fluorescence correlation spectroscopy with different fluorophores: evidence that the homopentameric 5-hydroxytryptamine type 3As receptor binds only one ligand. Biochemistry 38:8671–8681
Langmuir I (1918) The absorption of gases on plane surfaces of glass, mica and platinum. J Am Chem Soc 40:1361–1403
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Briddon SJ, Hill SJ (2007) Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes. Trends Pharmacol Sci 28:637–645
Acknowledgements
We thank the Swiss National Science Foundation (grant 31003A-118148) for financial support, GIMB for the gift of GR-119566X and GR-186741X, Dr. A. Surprenant (GIMB) for electrophysiological measurements, and all members of the Laboratory of Physical Chemistry of Polymers and Membranes (EPFL) that contributed to the work presented.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hovius, R. (2013). Characterization and Validation of Fluorescent Receptor Ligands: A Case Study of the Ionotropic Serotonin Receptor. In: Banghart, M. (eds) Chemical Neurobiology. Methods in Molecular Biology, vol 995. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-345-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-62703-345-9_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-344-2
Online ISBN: 978-1-62703-345-9
eBook Packages: Springer Protocols